NMPA (CFDA): More Class III, Class II Medical Devices and IVDs Exempted from Clinical Trial
NMPA (CFDA) published “Clinical Trial Exemptions Catalog for Medical Devices (Draft)” on August 1, 2019. It is an effort to implement risk-based clinical evaluation, and to make medical device clinical